EU pledges record 550 million-euro contribution to fight AIDS, TB and malaria

27 August 2019

During the G7 summit in Biarritz, France, over the weekend and Monday, the European Union announced a 550 million-euro ($611 million) pledge to The Global Fund.

The Fund is an international partnership to fight against AIDS, tuberculosis and malaria around the world. Its work has already saved 27 million lives since it was created in 2002.

European Commission President Jean-Claude Juncker said on this occasion: “The EU has been a strong supporter of the Global Fund since its creation, when the AIDS, malaria and tuberculosis epidemics seemed to be unbeatable. And today we are announcing a record contribution of a further 550 million euros. We hope the international community will follow suit and step up the fight to fulfil the Fund's target of ending these diseases' epidemics by 2030.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK